| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Adherence to the mediastinal staging guideline and unforeseen N2 disease in patients with resectable non-small cell lung cancer: Nationwide results from the Dutch Lung Cancer Audit - Surgery
|
Bousema, Jelle E.
|
|
|
142 |
C |
p. 51-58
|
artikel
|
| 2 |
Aims and Scope/Editorial Board
|
|
|
|
142 |
C |
p. iii
|
artikel
|
| 3 |
A multicenter study of thromboembolic events among patients diagnosed with ROS1-rearranged non-small cell lung cancer
|
Alexander, Marliese
|
|
|
142 |
C |
p. 34-40
|
artikel
|
| 4 |
A novel SOS1-ALK fusion variant in a patient with metastatic lung adenocarcinoma and a remarkable response to crizotinib
|
Chen, Hua-fei
|
|
|
142 |
C |
p. 59-62
|
artikel
|
| 5 |
A phase II study of the combination of gemcitabine and imatinib mesylate in pemetrexed-pretreated patients with malignant pleural mesothelioma
|
Zucali, Paolo Andrea
|
|
|
142 |
C |
p. 132-137
|
artikel
|
| 6 |
Aplastic anemia in a patient with advanced lung adenocarcinoma during first line osimertinib: A case report and literature review
|
Sala, Luca
|
|
|
142 |
C |
p. 120-122
|
artikel
|
| 7 |
ATOM: A phase II study to assess efficacy of preemptive local ablative therapy to residual oligometastases of NSCLC after EGFR TKI
|
Chan, Oscar S.H.
|
|
|
142 |
C |
p. 41-46
|
artikel
|
| 8 |
Comment on: ‘Hospital lung surgery volume and patient outcomes’
|
Stirling, Rob
|
|
|
142 |
C |
p. 138-139
|
artikel
|
| 9 |
Contents
|
|
|
|
142 |
C |
p. v-vi
|
artikel
|
| 10 |
Efficacy and safety of necitumumab and pembrolizumab combination therapy in patients with Stage IV non-small cell lung cancer
|
Besse, Benjamin
|
|
|
142 |
C |
p. 63-69
|
artikel
|
| 11 |
Erratum to “Timing in combination with radiotherapy and patterns of disease progression in non-small cell lung cancer treated with EGFR-TKI” [Lung Cancer, 140 (February) (2020) 65–70]
|
Tang, Yi
|
|
|
142 |
C |
p. 142
|
artikel
|
| 12 |
Impressive clinical response to anti-PD-1 therapy in epithelioid mesothelioma with high clonal PD-L1 expression and EML4-ALK rearrangement
|
Bronte, Giuseppe
|
|
|
142 |
C |
p. 47-50
|
artikel
|
| 13 |
Is it necessary to sample the contralateral nodal stations by EBUS-TBNA in patients with lung cancer and clinical N0 / N1 on PET-CT?
|
Serra, Pere
|
|
|
142 |
C |
p. 9-12
|
artikel
|
| 14 |
Neighborhood context and non-small cell lung cancer outcomes in Florida non-elderly patients by race/ethnicity
|
Johnson, Asal M.
|
|
|
142 |
C |
p. 20-27
|
artikel
|
| 15 |
PD-L1 expression and T cells infiltration in patients with uncommon EGFR-mutant non-small cell lung cancer and the response to immunotherapy
|
Chen, Kaiyan
|
|
|
142 |
C |
p. 98-105
|
artikel
|
| 16 |
Quantifying potential confounders of panel-based tumor mutational burden (TMB) measurement
|
Budczies, Jan
|
|
|
142 |
C |
p. 114-119
|
artikel
|
| 17 |
Reply to the letter-to-the editor “Hospital volume and the case for centralisation of surgical services”
|
Thai, A.A.
|
|
|
142 |
C |
p. 140-141
|
artikel
|
| 18 |
RET isoform-specific interaction with scaffold protein Ezrin promotes cell migration and chemotaxis in lung adenocarcinoma
|
Moodley, Serisha
|
|
|
142 |
C |
p. 123-131
|
artikel
|
| 19 |
Severe symptoms persist for Up to one year after diagnosis of stage I-III lung cancer: An analysis of province-wide patient reported outcomes
|
Hirpara, Dhruvin H.
|
|
|
142 |
C |
p. 80-89
|
artikel
|
| 20 |
Socioeconomic differences and lung cancer survival in Germany: Investigation based on population-based clinical cancer registration
|
Finke, Isabelle
|
|
|
142 |
C |
p. 1-8
|
artikel
|
| 21 |
Stable and discriminating radiomic predictor of recurrence in early stage non-small cell lung cancer: Multi-site study
|
Khorrami, Mohammadhadi
|
|
|
142 |
C |
p. 90-97
|
artikel
|
| 22 |
Stepwise flowchart for decision making on sublobar resection through the estimation of spread through air space in early stage lung cancer1
|
Suh, Jee Won
|
|
|
142 |
C |
p. 28-33
|
artikel
|
| 23 |
Stereotatic radiotherapy in metastatic non-small cell lung cancer: Combining immunotherapy and radiotherapy with a focus on liver metastases
|
Corrao, Giulia
|
|
|
142 |
C |
p. 70-79
|
artikel
|
| 24 |
Survival comparison of Three histological subtypes of lung squamous cell carcinoma: A population-based propensity score matching analysis
|
An, Na
|
|
|
142 |
C |
p. 13-19
|
artikel
|
| 25 |
Synergizing systemic responses by combining immunotherapy with radiotherapy in metastatic non-small cell lung cancer: The potential of the abscopal effect
|
Theelen, Willemijn SME
|
|
|
142 |
C |
p. 106-113
|
artikel
|
Tijdschrift beschrijving